Product Code: 23EL-822-4035
Please note: This is a Single Viewer registration for one participant for the on-demand version of this program. Access instructions for the on-demand version of this program will be provided via email approximately 3-10 business days after the live program has occurred and the on-demand version is available. If registering after the on-demand version is available, immediate access is granted via the AABB Education Platform at https://education.aabb.org.
If you registered for the live program you do not need to register for this on-demand eCast (access to the on-demand eCast was included with the live program registration).
If you are interested in presenting this program to a group, please see the “eCast Registration Form– Group Viewing” form on the program page.
Program Description: A broad variety of cell types are being utilized as therapeutics in the cellular therapy field. The most commonly used cellular therapy products (CTP) are stem cells and T cells. Full characterization of CTP requires that cell analytics such as - cell identity, cell viability, cell purity and cell potency be assessed for the product to be safe and effective. The program faculty will describe the current characterization strategies and analytical tools that cellular therapy laboratories and manufacturers use to measure identity, viability, purity and potency of CTPs along with the benefits and limitations of each of these methodologies.
Discussion on product release criteria as to what CTP characterization should be obtained before a cellular therapy product may leave the control of the collection or processing facility will also be part of this program. This includes assessment of all the cell attributes as mentioned above and in addition includes sterility testing and stability testing. This program will also cover future opportunities and techniques on the horizon for more in-depth and automated monitoring of cell analytics.
